Out of the program
Tuesday, May 26

• Starting a development project/TPP
• Regulatory strategies in drug development
• Medicinal Chemistry
• Patent/IP
• Assay development and hit identification
• ADME and drug metabolism
• Translational science/biomarkers

Wednesday, May 27

• PK (& PK-PD relationships)
• PD studies / in Vivo-Pharmacology
• NonClinical safety studies
• Preclinical formulation
• CMC regulatory strategies- from idea to IMPD
• Manufacturing of active pharmaceutical ingredient
• Analytical chemistry in drug development
• Quality (QA/QC)
• Pharmaceutical Development incl. manufacturing

Thursday, May 28

• Clinical trials
• Applications for clinical trials
• Health economics and reimbursement
• Strategic business development
• Licensing strategies among big pharma
• Financing
• Taking project from idea to a late-stage clinical development and beyond